Nitrous oxide misuse — neuropsychiatric presentation
N2O misuse · Psychiatry / Behavioural
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
Recreational nitrous oxide ('nos', 'balloons') inactivates vitamin B12, causing a functional deficiency that produces subacute combined degeneration of the cord, peripheral neuropathy and neuropsychiatric symptoms (low mood, psychosis, cognitive impairment). It is now a controlled substance in the UK and increasingly seen in young people.
Red flags
- Progressive ataxia, limb weakness or sensory loss (myelopathy)
- Sphincter disturbance
- Psychosis or marked cognitive impairment
- Megaloblastic anaemia
- Thromboembolism (hyperhomocysteinaemia risk)
Assessment
Differential diagnosis
- Subacute combined degeneration of the cord (B12 functional deficiency)
- Guillain-Barré syndrome or other neuropathy
- Primary B12/folate deficiency
- Multiple sclerosis or other demyelination
- Functional neurological disorder; psychiatric illness
Investigations
- Serum B12 (may be normal despite functional deficiency), active B12, homocysteine and methylmalonic acid (raised — more sensitive)
- FBC and blood film (macrocytosis, hypersegmented neutrophils)
- MRI spine (dorsal column signal change) if myelopathy suspected
- Nerve conduction studies for neuropathy
- Folate, U&E, LFTs; exclude other causes
Management
- Take a focused substance-use history (quantity, frequency of N2O use)
- Examine for peripheral neuropathy and myelopathy (sensory loss, ataxia, positive Romberg, brisk reflexes with upgoing plantars)
- Send homocysteine/methylmalonic acid (more sensitive than serum B12)
- Start high-dose B12 replacement promptly — do not wait for levels if clinical picture fits
- Treat neuropsychiatric symptoms (psychosis/low mood) supportively
- Advise cessation and refer to substance-misuse services
- Refer to neurology for myelopathy/neuropathy
- Arrange follow-up to monitor neurological recovery
Drugs & doses
Hydroxocobalamin — 1 mg IM on alternate days (e.g. for ~2 weeks) then maintenance; start early on clinical suspicion
Folic acid — 5 mg PO OD once B12 replacement started (avoid giving folate alone)
Lorazepam — 1-2 mg PO/IM for acute agitation/psychosis if needed; max 4 mg/24h
Analgesia (e.g. amitriptyline/gabapentin, specialist-led) for neuropathic pain
Disposition
Admit patients with myelopathy or significant neurological deficit for B12 replacement and neurology input; discharge milder cases with early B12, GP/neurology follow-up and substance-misuse referral, involving psychiatry for neuropsychiatric symptoms.
Complications & pitfalls
- Irreversible spinal cord and nerve damage if untreated
- Permanent gait and sensory impairment
- Venous thromboembolism from hyperhomocysteinaemia
- Psychiatric morbidity
- Falls and functional disability
Exam pearls
- Serum B12 can be normal — homocysteine and methylmalonic acid are more sensitive markers of functional deficiency
- Start B12 replacement on clinical suspicion; do not await results — early treatment improves recovery
- Give folate only after starting B12 to avoid worsening neurological deficit
- Ask young people with neuropathy/myelopathy specifically about nitrous oxide use
- N2O is now a Class C controlled substance in the UK — document and advise accordingly
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.